| ASCUS | Atypical Squamous Cells of Undetermined Significance |
| B12 | Vitamin B12 |
| CIN1 | Cervical Intraepithelial Neoplasia Grade 1 |
| CIN2/CIN3 | Cervical Intraepithelial Neoplasia Grade 2/Grade 3 |
| E6/E7 | Oncogenic Proteins E6 and E7 |
| EGCG | Epigallocatechin Gallate |
| FA | Folic Acid |
| FDA | Food and Drug Administration |
| HA | Hyaluronic Acid |
| HIV | Human Immunodeficiency Virus |
| HPV | Human Papillomavirus |
| HR | High-Risk |
| HSIL | High-Grade Squamous Intraepithelial Lesion |
| IFN-γ | Interferon-gamma |
| IL | Interleukin (e.g., IL12) |
| LEEP | Loop Electrosurgical Excision Procedure |
| LMICs | Low- and Middle-Income Countries |
| LR | Low-Risk |
| LSIL | Low-Grade Squamous Intraepithelial Lesion |
| N/A | Not applicable |
| p53 | Tumor Suppressor Protein p53 |
| pRb | Retinoblastoma Protein |
| PSP | Polysaccharopeptides |
| TNF-α | Tumor necrosis factor alpha |